IRIX - イリデックス （IRIDEX Corporation） イリデックスIRIXのチャート
IRIXの企業情報
| symbol | IRIx |
|---|---|
| 会社名 | IRIDEX Corp. （イリデックス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 イリデックス（IRIDEX Corporation）は眼科学における目の疾患の治療用の治療ベースのレーザーシステム、送達デバイス及び消耗器具のグローバルなプロバイダー。同社は主に眼科に集中する。同社の眼科治療商品は主に直販の方式で米国内に販売されて、100カ国以上における約70の独立系代理販売業者を介して国際的に販売される。同社の眼科治療商品は「IQ」と「OcuLight」レーザーシステム、消耗品、及びサービスと支援業務を含む。同社の「IQ」製品群は「IQ 532」、「IQ 577」と「IQ 810」のレーザー光凝固システムを含み、「OcuLight」商品は「OcuLight TX」、「OcuLight Symphony」（レーザー・デリバリー・システム）、「OcuLight SL」、「OcuLight SLx」、「OcuLight GL」及び「OcuLight GLx」のレーザー光凝固システムを含む。平成24年2月、同社はCutera Inc.に美容事業を譲渡した。 イリデックスは医療用レ―ザ―システムを提供する米国企業。眼疾患治療に使用されるレ―ザ―システム、送達デバイス及び消耗器具類などを開発、製造。糖尿病性網膜症、緑内障、加齢性黄斑変性症などの視力を脅かす眼の疾患を対象とする。販売代理店を通じて、世界的に製品を販売。本社はカリフォルニア州。 IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA. |
| 本社所在地 | 1212 Terra Bella Avenue Mountain View CA 94043-1824 USA |
| 代表者氏名 | William M. Moore ウィリアム・M・ムーア |
| 代表者役職名 | Chairman of the Board Interim President and Chief Executive Officer |
| 電話番号 | +1 650-940-4700 |
| 設立年月日 | 32540 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1996年 |
| 従業員数 | 154人 |
| url | www.iridex.com |
| nasdaq_url | https://www.nasdaq.com/symbol/irix |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -14.49200 |
| 終値（lastsale） | 5.925 |
| 時価総額（marketcap） | 69110260.575 |
| 時価総額 | 時価総額（百万ドル） 69.31863 |
| 売上高 | 売上高（百万ドル） 40.92100 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 53.27363 |
| 当期純利益 | 当期純利益（百万ドル） -15.13400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 IRIDEX Corporation revenues decreased 3% to $19.8M. Net loss increased 49% to $6.9M. Revenues reflect United States segment decrease of 14% to $10M Asia/Pacific Rim segment decrease of 2% to $3.9M. Higher net loss reflects Selling/General/Admin. Expense increase of 26% to $8M (expense) Selling expenses increase of 25% to $4.4M (expense). |
IRIXのテクニカル分析
IRIXのニュース
IRIDEX Announces Second Quarter 2020 Financial Results 2020/08/06 20:05:00 GlobeNewswire
MOUNTAIN VIEW, Calif., Aug. 06, 2020 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the second quarter ended…
Insights on the Retinal Surgery Devices Market to 2027 - Featuring Geuder, Insight Instruments & IRIDEX Among Others - ResearchAndMarkets.com 2020/06/11 10:35:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Retinal Surgery Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Retinal Surgery Devices market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.8%. Vitrectomy Packs, one of the segments analyzed and sized in this study, is forecast to grow at over 7.
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates 2020/05/12 00:15:05 Zacks Investment Research
Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
$67B+ Ophthalmic Devices Market Analysis (2015-2026) Featuring Alcon Labs, Carl Zeiss, Topcon, Valeant Pharma, Iridex, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products 2020/01/27 21:15:00 PR Newswire
DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies" report has been added to ResearchAndMarkets.com's offering. Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026…
Will Iridex (IRIX) Report Negative Earnings Next Week? What You Should Know 2019/10/31 14:35:04 Zacks Investment Research
Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights on the Retinal Surgery Devices Market to 2027 - Featuring Geuder, Insight Instruments & IRIDEX Among Others - ResearchAndMarkets.com 2020/06/11 10:35:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Retinal Surgery Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Retinal Surgery Devices market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.8%. Vitrectomy Packs, one of the segments analyzed and sized in this study, is forecast to grow at over 7.
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates 2020/05/12 00:15:05 Zacks Investment Research
Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
$67B+ Ophthalmic Devices Market Analysis (2015-2026) Featuring Alcon Labs, Carl Zeiss, Topcon, Valeant Pharma, Iridex, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products 2020/01/27 21:15:00 PR Newswire
DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies" report has been added to ResearchAndMarkets.com's offering. Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026…
Will Iridex (IRIX) Report Negative Earnings Next Week? What You Should Know 2019/10/31 14:35:04 Zacks Investment Research
Iridex (IRIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Industry Rank Highlights: Lumentum, Cuter and Iridex 2019/09/25 14:39:00 Zacks Investment Research
The Zacks Industry Rank Highlights: Lumentum, Cuter and Iridex
Insights on the Retinal Surgery Devices Market to 2027 - Featuring Geuder, Insight Instruments & IRIDEX Among Others - ResearchAndMarkets.com 2020/06/11 10:35:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Retinal Surgery Devices - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Retinal Surgery Devices market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 6.8%. Vitrectomy Packs, one of the segments analyzed and sized in this study, is forecast to grow at over 7.
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates 2020/05/12 00:15:05 Zacks Investment Research
Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
$67B+ Ophthalmic Devices Market Analysis (2015-2026) Featuring Alcon Labs, Carl Zeiss, Topcon, Valeant Pharma, Iridex, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products 2020/01/27 21:15:00 PR Newswire
DUBLIN, Jan. 27, 2020 /PRNewswire/ -- The "Ophthalmic Devices Market Global Forecast by Application, Products, Regions, Companies" report has been added to ResearchAndMarkets.com's offering. Global Ophthalmic Device Market is Projected to Reach More Than US$ 67 Billion by the End of 2026…